Thinking beyond sepsis to unmask a metabolic mystery: a rare case of neonatal maple syrup urine disease

Dinkar Raut; Sagar Yamnaji Walhekar; Anjini Misra; Rachna Singh

doi:10.18203/2349-3291.ijcp20250780

Authors

Dinkar Raut Neonatal and Pediatric Intensivist, Yogita Pediatric Critical Care Hospital and Nursing Home, Beed, Maharashtra, India
Sagar Yamnaji Walhekar Neonatal and Pediatric Intensivist, Yogita Pediatric Critical Care Hospital and Nursing Home, Beed, Maharashtra, India
Anjini Misra Department of Pediatrics, Government Medical College, Nagpur, Maharashtra, India
Rachna Singh Punjabrao Deshmukh Medical College and Hospital, Amravati, Maharashtra, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20250780

Keywords:

Maple syrup urine disease, Consanguineous marriage, Prognosis, Feeding difficulty

Abstract

Maple syrup urine disease (MSUD) was first reported by paediatrician Menkes in 1954, as the α-ketoacid excreted in urine smells like maple syrup. MSUD is a rare genetic disorder which manifested as impaired branched-chain amino acid (BCAA) metabolism caused by branched-chain α-ketoacid dehydrogenase (BCKD) complex deficiency. Early diagnosis and treatment of MSUD is important for better outcomes. Feed intolerance, history of consanguinity between parents and that peculiar odour of maple syrup in urine should raise suspicion of the above. Timely referral, especially by clinicians practising in rural areas, is essential for early diagnosis and treatment. We present a case of MSUD with poor prognosis probably due to advanced disease at the time of presentation. The case highlights the importance of suspicion and early diagnosis of MSUD, as well as thinking beyond sepsis as the root of all problems.

Metrics

Metrics Loading ...

References

Strauss KA, Puffenberger EG, Morton DH. Maple syrup urine disease. Develop Med Child Neurol. 1959;1:104-5.

Blackburn PR, Gass JM, Vairo FPE, Farnham KM, Atwal HK, Macklin S, et al. Maple syrup urine disease: mechanisms and management. Appl Clin Genet. 2017;10:57-66. DOI: https://doi.org/10.2147/TACG.S125962

Hassan SA, Gupta V. Maple syrup urine disease. StatPearls. StatPearls Publishing. 2025.

Fingerhut R. Recall rate and positive predictive value of MSUD screening is not influenced by hydroxyproline. Eur J Pediatr. 2009;168(5):599-604. DOI: https://doi.org/10.1007/s00431-008-0804-0

Zinnanti WJ, Lazovic J, Griffin K, Skvorak KJ, Paul HS, Homanics GE, et al. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain. 2009;132(4):903-18. DOI: https://doi.org/10.1093/brain/awp024

Ajmera P, Agarwal A, Dahiya A, Parripati VK. Maple Syrup Urine Disease: An uncommon cause of neonatal febrile seizures. Cureus. 2023;15(6):e40826.

Tabbouche O, Saker A, Mountain H. Identification of three novel mutations by studying the molecular genetics of Maple Syrup Urine Disease (MSUD) in the Lebanese population. Mol Genet Metab Rep. 20141:273-9. DOI: https://doi.org/10.1016/j.ymgmr.2014.03.005

Mengler K, Garbade SF, Gleich F, Thimm E, May P, Lindner M, et al. Treatment Outcomes for Maple Syrup Urine Disease Detected by Newborn Screening. Pediatrics. 2024;154(2):e2023064370. DOI: https://doi.org/10.1542/peds.2023-064370

Harshyenee KK, Ajmera P, Agarwal A, Dahiya A, Parripati VK. Maple syrup urine disease: an uncommon cause of neonatal febrile seizures. Cureus. 2023;15(6):e40826.

Liu Q, Li F, Zhou J, Liu X, Peng J, Gong L. Neonatal maple syrup urine disease case report and literature review. Medicine. 2022;101(50):e32174. DOI: https://doi.org/10.1097/MD.0000000000032174